E-MAIL: your-email@mail.com
E-MAIL: your-email@mail.com
India’s drug regulator, CDSCO, clears Takeda’s recombinant live attenuated dengue vaccine for prevention of dengue in individuals aged 4–60 years.
imphoenix82
A 65-year-old woman underwent a modified radical mastectomy, prosthetic aortic valve replacement and single-vessel coronary artery bypass grafting in a rare six-hour surgery that successfully treated breast cancer and two life-threatening heart conditions.
imphoenix82
Novartis is helping improve access to Fabhalta for patients with primary immunoglobulin A nephropathy (IgAN) through a variety of support programmes.
imphoenix82
Stryker has announced the U S commercial launch of Mako RPS(Robotic Power System) for total knee replacement procedures, expanding the Mako portfolio beyond robotic-arm assisted surgery. The launch introduces the Mako Handheld Robotics platform alongside Mako SmartRobotics with Mako 4, Stryker’s multi-specialty robotic-arm assisted platform. Designed to provide surgeons with an intuitive handheld robotic experience, Mako RPS […]
imphoenix82
The acquisition adds SPR’s FDA-cleared SPRINT PNS System, a short-term percutaneous peripheral nerve stimulation (PNS) therapy, to Medtronic’s pain therapy portfolio.
imphoenix82
The baby’s life-saving, limb-preserving treatment, costing approximately Rs 30–35 lakh, was funded through an initiative launched by HCG Cancer Centre, Bangalore.
imphoenix82
The partnership aims to foster research, innovation, training and capacity building in sports medicine to better support Indian athletes.
imphoenix82
Dr. Shelden Martin of OrthoArizona performed the augmented reality-assisted shoulder replacement surgery on a patient with degenerative arthritis and rotator cuff pathology.
imphoenix82
Johnson & Johnson’s dual energy catheter ablation platform gives physicians the flexibility to choose either radiofrequency or pulsed field energy based on patient anatomy and case complexity.
imphoenix82
WHO calls for placing people affected by cancer at the centre of cancer control efforts
imphoenix82HealthXplore is a digital platform dedicated to delivering insights into what’s new and what’s next in healthcare, pharmaceuticals, and medical innovation. We aim to bridge the gap between complex industry developments and informed audiences by presenting credible, timely, and engaging content.
Contact: +91 9354115542
HealthXploreIndia @2026. All Rights Reserved.
